Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Prevalence and types of rectal douches used for anal intercourse: results from an international survey

Authors: Marjan Javanbakht, Shauna Stahlman, Jim Pickett, Marc-André LeBlanc, Pamina M Gorbach

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Rectal products used with anal intercourse (AI) may facilitate transmission of STIs/HIV. However, there is limited data on rectal douching behavior in populations practicing AI. We examined the content, types of products, rectal douching practices and risk behaviors among those reporting AI.

Methods

From August 2011 to May 2012, 1,725 women and men reporting receptive AI in the past 3 months completed an internet-based survey on rectal douching practices. The survey was available in English, French, German, Mandarin, Portuguese, Russian, Spanish, and Thai and included questions on sexual behaviors associated with AI including rectal douching. Differences by rectal douching practices were evaluated using chi-square methods and associations between reported douching practices and other factors including age and reported STI history were evaluated using logistic regression analysis.

Results

Respondents represented 112 countries, were mostly male (88%), and from North America (55%) or Europe (22%). Among the 1,339 respondents (66%) who reported rectal douching, most (83%) reported always/almost always douching before receptive AI. The majority of rectal douchers reported using non-commercial/homemade products (93%), with water being the most commonly used product (82%). Commercial products were used by 31%, with the most common product being saline-based (56%). Rectal douching varied by demographic and risk behaviors. The prevalence of rectal douching was higher among men (70% vs. 32%; p-value < .01), those reporting substance-use with sex (74% vs. 46%; p-value < .01), and those reporting an STI in the past year (69% vs. 57% p-value < .01) or ever testing HIV-positive (72% vs. 53%; p-value < .01). In multivariable analysis, adjusting for age, gender, region, condom and lubricant use, substance use, and HIV-status, douchers had a 74% increased odds of reporting STI in the past year as compared to non-douchers [adjusted odds ratio (AOR) = 1.74; 95% CI 1.01-3.00].

Conclusion

Given that rectal douching before receptive AI is common and because rectal douching was associated with other sexual risk behaviors the contribution of this practice to the transmission and acquisition of STIs including HIV may be important.
Appendix
Available only for authorised users
Literature
1.
go back to reference Royce RA, Sena A, Cates W, Cohen MS: Sexual transmission of HIV. N Engl J Med. 1997, 336 (15): 1072-1078.CrossRefPubMed Royce RA, Sena A, Cates W, Cohen MS: Sexual transmission of HIV. N Engl J Med. 1997, 336 (15): 1072-1078.CrossRefPubMed
2.
go back to reference Van Damme L, Ramjee G, Alary M, et al: Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002, 360: 971-977.CrossRefPubMed Van Damme L, Ramjee G, Alary M, et al: Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet. 2002, 360: 971-977.CrossRefPubMed
3.
go back to reference Phillips DM, Sudol KM, Taylor CL, Guichard L, Elsen R, Maguire RA: Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs. Contraception. 2004, 70: 107-110.CrossRefPubMed Phillips DM, Sudol KM, Taylor CL, Guichard L, Elsen R, Maguire RA: Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs. Contraception. 2004, 70: 107-110.CrossRefPubMed
4.
go back to reference Tabet SR, Surawicz C, Horton S, et al: Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. Sex Transm Dis. 1999, 26: 564-571.CrossRefPubMed Tabet SR, Surawicz C, Horton S, et al: Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. Sex Transm Dis. 1999, 26: 564-571.CrossRefPubMed
5.
go back to reference Adriaens E, Remon JP: Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay. Sex Transm Dis. 2008, 35 (5): 512-516.CrossRefPubMed Adriaens E, Remon JP: Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay. Sex Transm Dis. 2008, 35 (5): 512-516.CrossRefPubMed
6.
go back to reference Sudol KM, Phillips DM: Relative safety of sexual lubricants for rectal intercourse. Sex Transm Dis. 2004, 31: 346-349.CrossRefPubMed Sudol KM, Phillips DM: Relative safety of sexual lubricants for rectal intercourse. Sex Transm Dis. 2004, 31: 346-349.CrossRefPubMed
7.
go back to reference Russo J, Rohan LC, Moncla B, Na Ayudhya RP, Wang L, Cost M, Pryke K, LeBlanc M-A, Pickett J, CS D: Safety and Anti-HIV Activity of Over-the-Counter Lubricant Gels. Microbicides 2010. 2010, PA: Pittsburgh Russo J, Rohan LC, Moncla B, Na Ayudhya RP, Wang L, Cost M, Pryke K, LeBlanc M-A, Pickett J, CS D: Safety and Anti-HIV Activity of Over-the-Counter Lubricant Gels. Microbicides 2010. 2010, PA: Pittsburgh
8.
go back to reference Begay O, Jean-Pierre N, Abraham CJ, Chudolij A, Seidor S, Rodriguez A, Ford BE, Henderson M, Katz D, Zydowsky T, et al: Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. AIDS Res Hum Retroviruses. 2011, 27 (9): 1019-1024.CrossRefPubMedPubMedCentral Begay O, Jean-Pierre N, Abraham CJ, Chudolij A, Seidor S, Rodriguez A, Ford BE, Henderson M, Katz D, Zydowsky T, et al: Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. AIDS Res Hum Retroviruses. 2011, 27 (9): 1019-1024.CrossRefPubMedPubMedCentral
9.
go back to reference Dezzutti CS, Brown ER, Moncla B, Russo J, Cost M, Wang L, Uranker K, Kunjara Na Ayudhya RP, Pryke K, Pickett J, et al: Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity. PLoS One. 2012, 7 (11): e48328-CrossRefPubMedPubMedCentral Dezzutti CS, Brown ER, Moncla B, Russo J, Cost M, Wang L, Uranker K, Kunjara Na Ayudhya RP, Pryke K, Pickett J, et al: Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity. PLoS One. 2012, 7 (11): e48328-CrossRefPubMedPubMedCentral
10.
go back to reference Fuchs EJ, et al: Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis. 2007, 195 (5): 703-710.CrossRefPubMed Fuchs EJ, et al: Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis. 2007, 195 (5): 703-710.CrossRefPubMed
11.
go back to reference Gorbach PM, Weiss RE, Fuchs E, Jeffries RA, Hezerah M, Brown S, Voskanian A, Robbie E, Anton P, Cranston RD: The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk. Sex Transm Dis. 2012, 39 (1): 59-64.CrossRefPubMedPubMedCentral Gorbach PM, Weiss RE, Fuchs E, Jeffries RA, Hezerah M, Brown S, Voskanian A, Robbie E, Anton P, Cranston RD: The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk. Sex Transm Dis. 2012, 39 (1): 59-64.CrossRefPubMedPubMedCentral
12.
go back to reference Peters SE, Beck-Sague CM, Farshy CE, Gibson I, Kubota KA, Solomon F, Morse SA, Sievert AJ, Black CM: Behaviors associated with Neisseria gonorrhoeae and Chlamydia trachomatis: cervical infection among young women attending adolescent clinics. Clin Pediatr. 2000, 39 (3): 173-177.CrossRef Peters SE, Beck-Sague CM, Farshy CE, Gibson I, Kubota KA, Solomon F, Morse SA, Sievert AJ, Black CM: Behaviors associated with Neisseria gonorrhoeae and Chlamydia trachomatis: cervical infection among young women attending adolescent clinics. Clin Pediatr. 2000, 39 (3): 173-177.CrossRef
13.
go back to reference Tsai CS, Shepherd BE, Vermund SH: Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol. 2009, 200 (1): e31-e38.CrossRef Tsai CS, Shepherd BE, Vermund SH: Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol. 2009, 200 (1): e31-e38.CrossRef
14.
go back to reference Brotman RM, Klebanoff MA, Nansel TR, Andrews WW, Schwebke JR, Zhang J, Yu KF, Zenilman JM, Scharfstein DO: A longitudinal study of vaginal douching and bacterial vaginosis–a marginal structural modeling analysis. Am J Epidemiol. 2008, 168 (2): 188-196.CrossRefPubMedPubMedCentral Brotman RM, Klebanoff MA, Nansel TR, Andrews WW, Schwebke JR, Zhang J, Yu KF, Zenilman JM, Scharfstein DO: A longitudinal study of vaginal douching and bacterial vaginosis–a marginal structural modeling analysis. Am J Epidemiol. 2008, 168 (2): 188-196.CrossRefPubMedPubMedCentral
15.
go back to reference Annang L, Grimley DM, Hook EW: Vaginal douche practices among black women at risk: exploring douching prevalence, reasons for douching, and sexually transmitted disease infection. Sex Transm Dis. 2006, 33 (4): 215-219.CrossRefPubMed Annang L, Grimley DM, Hook EW: Vaginal douche practices among black women at risk: exploring douching prevalence, reasons for douching, and sexually transmitted disease infection. Sex Transm Dis. 2006, 33 (4): 215-219.CrossRefPubMed
16.
go back to reference Coates RA, Calzavara LM, Read SE, Fanning MM, Shepherd FA, Klein MH, Johnson JK, Soskolne CL: Risk factors for HIV infection in male sexual contacts of men with AIDS or an AIDS-related condition. Am J Epidemiol. 1988, 128 (4): 729-739.PubMed Coates RA, Calzavara LM, Read SE, Fanning MM, Shepherd FA, Klein MH, Johnson JK, Soskolne CL: Risk factors for HIV infection in male sexual contacts of men with AIDS or an AIDS-related condition. Am J Epidemiol. 1988, 128 (4): 729-739.PubMed
17.
go back to reference Moss AR, Osmond D, Bacchetti P, Chermann JC, Barre-Sinoussi F, Carlson J: Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol. 1987, 125 (6): 1035-1047.PubMed Moss AR, Osmond D, Bacchetti P, Chermann JC, Barre-Sinoussi F, Carlson J: Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol. 1987, 125 (6): 1035-1047.PubMed
18.
go back to reference Carballo-Dieguez A, Bauermeister JA, Ventuneac A, Dolezal C, Balan I, Remien RH: The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides. AIDS Behav. 2008, 12 (6): 860-866.CrossRefPubMed Carballo-Dieguez A, Bauermeister JA, Ventuneac A, Dolezal C, Balan I, Remien RH: The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides. AIDS Behav. 2008, 12 (6): 860-866.CrossRefPubMed
19.
go back to reference Chmiel JS, Detels R, Kaslow RA, Van Raden M, Kingsley LA, Brookmeyer R: Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol. 1987, 126 (4): 568-577.PubMed Chmiel JS, Detels R, Kaslow RA, Van Raden M, Kingsley LA, Brookmeyer R: Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol. 1987, 126 (4): 568-577.PubMed
20.
go back to reference De Vries HJ, van der Bij AK, Fennema JS, Smit C, De Wolf F, Prins M, Coutinho RA, Morre SA: Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior. Sex Transm Dis. 2008, 35 (2): 203-208.CrossRefPubMed De Vries HJ, van der Bij AK, Fennema JS, Smit C, De Wolf F, Prins M, Coutinho RA, Morre SA: Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior. Sex Transm Dis. 2008, 35 (2): 203-208.CrossRefPubMed
21.
go back to reference Schreeder MT, Thompson SE, Hadler SC, Berquist KR, Zaidi A, Maynard JE, Ostrow D, Judson FN, Braff EH, Nylund T, et al: Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis. 1982, 146 (1): 7-15.CrossRefPubMed Schreeder MT, Thompson SE, Hadler SC, Berquist KR, Zaidi A, Maynard JE, Ostrow D, Judson FN, Braff EH, Nylund T, et al: Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis. 1982, 146 (1): 7-15.CrossRefPubMed
22.
go back to reference Calabrese SK, Rosenberger JG, Schick VR, Novak DS, Reece M: An event-level comparison of risk-related sexual practices between black and other-race men who have sex with men: condoms, semen, lubricant, and rectal douching. AIDS Patient Care STDS. 2013, 27 (2): 77-84.CrossRefPubMedPubMedCentral Calabrese SK, Rosenberger JG, Schick VR, Novak DS, Reece M: An event-level comparison of risk-related sexual practices between black and other-race men who have sex with men: condoms, semen, lubricant, and rectal douching. AIDS Patient Care STDS. 2013, 27 (2): 77-84.CrossRefPubMedPubMedCentral
23.
go back to reference Kinsler JJ, Galea JT, Lama JR, Segura P, Peinado J, Casapia M, Ortiz A, Nadjat-Haiem C, Montano SM, Sanchez J: Rectal douching among Peruvian men who have sex with men, and acceptability of a douche-formulated rectal microbicide to prevent HIV infection. Sex Transm Infect. 2013, 89 (1): 62-CrossRefPubMed Kinsler JJ, Galea JT, Lama JR, Segura P, Peinado J, Casapia M, Ortiz A, Nadjat-Haiem C, Montano SM, Sanchez J: Rectal douching among Peruvian men who have sex with men, and acceptability of a douche-formulated rectal microbicide to prevent HIV infection. Sex Transm Infect. 2013, 89 (1): 62-CrossRefPubMed
24.
go back to reference Schmelzer M, Schiller LR, Meyer R, Rugari SM, Case P: Safety and effectiveness of large-volume enema solutions. Appl Nurs Res. 2004, 17 (4): 265-274.PubMed Schmelzer M, Schiller LR, Meyer R, Rugari SM, Case P: Safety and effectiveness of large-volume enema solutions. Appl Nurs Res. 2004, 17 (4): 265-274.PubMed
25.
go back to reference Pietila JA, Kinnunen J, Linden H: The cleansing enema. How many for a good quality double-contrast enema?. Acta radiologica. 1990, 31 (5): 489-492.PubMed Pietila JA, Kinnunen J, Linden H: The cleansing enema. How many for a good quality double-contrast enema?. Acta radiologica. 1990, 31 (5): 489-492.PubMed
26.
go back to reference Niv Y: Enema preparation for proctosigmoidoscopy does not cause mucosal changes. Endoscopy. 1990, 22 (4): 199-200.CrossRefPubMed Niv Y: Enema preparation for proctosigmoidoscopy does not cause mucosal changes. Endoscopy. 1990, 22 (4): 199-200.CrossRefPubMed
27.
go back to reference Schmelzer M, Case P, Chappell SM, Wright KB: Colonic cleansing, fluid absorption, and discomfort following tap water and soapsuds enemas. Appl Nurs Res. 2000, 13 (2): 83-91.CrossRefPubMed Schmelzer M, Case P, Chappell SM, Wright KB: Colonic cleansing, fluid absorption, and discomfort following tap water and soapsuds enemas. Appl Nurs Res. 2000, 13 (2): 83-91.CrossRefPubMed
28.
go back to reference Orchard JL, Lawson R: Severe colitis induced by soap enemas. South Med J. 1986, 79 (11): 1459-1460.CrossRefPubMed Orchard JL, Lawson R: Severe colitis induced by soap enemas. South Med J. 1986, 79 (11): 1459-1460.CrossRefPubMed
29.
go back to reference Meisel JL, Bergman D, Graney D, Saunders DR, Rubin CE: Human rectal mucosa: proctoscopic and morphological changes caused by laxatives. Gastroenterology. 1977, 72 (6): 1274-1279.PubMed Meisel JL, Bergman D, Graney D, Saunders DR, Rubin CE: Human rectal mucosa: proctoscopic and morphological changes caused by laxatives. Gastroenterology. 1977, 72 (6): 1274-1279.PubMed
30.
go back to reference Javanbakht M, Murphy R, Gorbach P, LeBlanc MA, Pickett J: Preference and practices relating to lubricant use during anal intercourse: implications for rectal microbicides. Sex Health. 2010, 7 (2): 193-198.CrossRefPubMed Javanbakht M, Murphy R, Gorbach P, LeBlanc MA, Pickett J: Preference and practices relating to lubricant use during anal intercourse: implications for rectal microbicides. Sex Health. 2010, 7 (2): 193-198.CrossRefPubMed
31.
go back to reference Semple SJ, Zians J, Strathdee SA, Patterson TL: Sexual marathons and methamphetamine use among HIV-positive men who have sex with men. Arch Sex Behav. 2009, 38 (4): 583-590.CrossRefPubMed Semple SJ, Zians J, Strathdee SA, Patterson TL: Sexual marathons and methamphetamine use among HIV-positive men who have sex with men. Arch Sex Behav. 2009, 38 (4): 583-590.CrossRefPubMed
32.
go back to reference Dursteler-MacFarland KM, Stohler R, Moldovanyi A, Rey S, Basdekis R, Gschwend P, Eschmann S, Rehm J: Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine. Drug Alcohol Depend. 2006, 81 (3): 231-239.CrossRefPubMed Dursteler-MacFarland KM, Stohler R, Moldovanyi A, Rey S, Basdekis R, Gschwend P, Eschmann S, Rehm J: Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine. Drug Alcohol Depend. 2006, 81 (3): 231-239.CrossRefPubMed
33.
go back to reference Panchal SJ, Muller-Schwefe P, Wurzelmann JI: Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract. 2007, 61 (7): 1181-1187.CrossRefPubMedPubMedCentral Panchal SJ, Muller-Schwefe P, Wurzelmann JI: Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract. 2007, 61 (7): 1181-1187.CrossRefPubMedPubMedCentral
34.
go back to reference Camilleri M: Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol. 2011, 106 (5): 835-842. quiz 843CrossRefPubMed Camilleri M: Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol. 2011, 106 (5): 835-842. quiz 843CrossRefPubMed
35.
go back to reference McGowan I, Dezzutti C: Rectal Microbicide Development. Curr Top Microbiol Immunol. 2013, epub McGowan I, Dezzutti C: Rectal Microbicide Development. Curr Top Microbiol Immunol. 2013, epub
36.
go back to reference Galea JT, Kinsler JJ, Imrie J, Nurena CR, Sanchez J, Cunningham WE: Rectal douching and implications for rectal microbicides among populations vulnerable to HIV in South America: a qualitative study. Sex Transm Infect. 2014, 90 (1): 33-35.CrossRefPubMed Galea JT, Kinsler JJ, Imrie J, Nurena CR, Sanchez J, Cunningham WE: Rectal douching and implications for rectal microbicides among populations vulnerable to HIV in South America: a qualitative study. Sex Transm Infect. 2014, 90 (1): 33-35.CrossRefPubMed
37.
go back to reference Carballo-Dieguez A, Bauermeister J, Ventuneac A, Dolezal C, Mayer K: Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men. Sex Transm Dis. 2010, 37 (4): 228-233.PubMedPubMedCentral Carballo-Dieguez A, Bauermeister J, Ventuneac A, Dolezal C, Mayer K: Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men. Sex Transm Dis. 2010, 37 (4): 228-233.PubMedPubMedCentral
38.
go back to reference Carballo-Dieguez A, Giguere R, Bauermeister J, Dolezal C, Leu CS, Valladares J, Febo I, Cranston RD, Mayer K, McGowan I: Adherence to rectal microbicide use among mainly ethnic minority young men who have sex with men (MSM): lessons from a 3-month placebo gel trial at three US sites. 7th Conference on HIV Pathogenesis, Treatment, and Prevention 30 June - 03 July, 2013. 2013, Malaysia: Kuala Lumpur Carballo-Dieguez A, Giguere R, Bauermeister J, Dolezal C, Leu CS, Valladares J, Febo I, Cranston RD, Mayer K, McGowan I: Adherence to rectal microbicide use among mainly ethnic minority young men who have sex with men (MSM): lessons from a 3-month placebo gel trial at three US sites. 7th Conference on HIV Pathogenesis, Treatment, and Prevention 30 June - 03 July, 2013. 2013, Malaysia: Kuala Lumpur
39.
go back to reference Marrazzo J, Ramjee G, Nair G, et al: Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN 003) [abstract 26LB]. 20th Conference on Retroviruses and Opportunistic Infections; March 3–6, 2013. 2013, GA: Atlanta Marrazzo J, Ramjee G, Nair G, et al: Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN 003) [abstract 26LB]. 20th Conference on Retroviruses and Opportunistic Infections; March 3–6, 2013. 2013, GA: Atlanta
40.
go back to reference Elford J, Bolding G, Davis M, Sherr L, Hart G: Web-based behavioral surveillance among men who have sex with men: a comparison of online and offline samples in London, UK. J Acquir Immune Defic Syndr. 2004, 35 (4): 421-426.CrossRefPubMed Elford J, Bolding G, Davis M, Sherr L, Hart G: Web-based behavioral surveillance among men who have sex with men: a comparison of online and offline samples in London, UK. J Acquir Immune Defic Syndr. 2004, 35 (4): 421-426.CrossRefPubMed
41.
go back to reference Rhodes SD, Bowie DA, Hergenrather KC: Collecting behavioural data using the world wide web: considerations for researchers. J Epidemiol Community Health. 2003, 57 (1): 68-73.CrossRefPubMedPubMedCentral Rhodes SD, Bowie DA, Hergenrather KC: Collecting behavioural data using the world wide web: considerations for researchers. J Epidemiol Community Health. 2003, 57 (1): 68-73.CrossRefPubMedPubMedCentral
Metadata
Title
Prevalence and types of rectal douches used for anal intercourse: results from an international survey
Authors
Marjan Javanbakht
Shauna Stahlman
Jim Pickett
Marc-André LeBlanc
Pamina M Gorbach
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-95

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.